Key result
Intermediate-risk BETTY score is linked to ~5-fold higher 30-day postoperative complication risk.
Why the study?
This study evaluated a new scoring system, the BETTY score, designed to predict 30-day patient outcomes after surgery.
Does the BETTY score predict 30-day postoperative outcomes in prostate cancer patients undergoing robot-assisted radical prostatectomy?
Cohort (n=297)
No
Does the BETTY score predict 30-day postoperative outcomes in prostate cancer patients undergoing robot-assisted radical prostatectomy?
Answers are grounded in this paper and cite their sources.
The BETTY score is a promising, easy-to-use tool for predicting 30-day postoperative outcomes in patients undergoing robot-assisted radical prostatectomy.
The aim of this study is to evaluate a new user-friendly scoring system, namely the BETTY score, that aims to predict 30-day patient outcomes after surgery. In this first description, we rely on a population of prostate cancer patients undergoing robot-assisted radical prostatectomy. The BETTY score includes the patient’s American Society of Anesthesiologists score, the body mass index, and intraoperative data, including operative time, estimated blood loss, any major intraoperative complications, hemodynamic, and/or respiratory instability. There is an inverse relationship between the score and severity. Three clusters assessing the risk of postoperative events were defined: low, intermediate, and high risk of postoperative events. A total of 297 patients was included. The median length of hospital stay was 1 day (IQR1-2). Unplanned visits, readmissions, any complications, and serious complications occurred in 17.2%, 11.8%, 28.3%, and 5% of cases, respectively. We found a statistically significant correlation between the BETTY score and all endpoints analyzed (all p ≤ 0.01). A total of 275, 20, and 2 patients were classified as low-, intermediate-, and high-risk according to the BETTY scoring system, respectively. Compared with low-risk patients, patients at intermediate-risk were associated with worse outcomes for all endpoints analyzed (all p ≤ 0.04). Future studies, in various surgical subspecialties, are ongoing to confirm the usefulness of this easy-to-use score in routine.
No takes yet. Share an insight, caveat, or question.
Baboudjian et al. (2023) conducted a cohort in Prostate cancer (n=297). Intermediate-risk BETTY score vs. Low-risk BETTY score was evaluated on Any 30-day postoperative complication (OR 5.4, 95% CI 2 to 15, p=<0.001). Patients classified as intermediate-risk by the BETTY score had a increased risk of any 30-day postoperative complication compared to low-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: